Cleared Traditional

K992704 - IL TEST VON WILLEBRAND FACTOR

K992704 is an FDA 510(k) clearance for IL TEST VON WILLEBRAND FACTOR, manufactured by Instrumentation Laboratory CO. The device is a Class 2 Hematology device with product code GGP cleared through the Traditional 510(k) pathway after a 81-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1999
Decision
81d
Days
Class 2
Risk

K992704 is an FDA 510(k) clearance for the IL TEST VON WILLEBRAND FACTOR. Classified as Test, Qualitative And Quantitative Factor Deficiency (product code GGP), Class II - Special Controls.

Submitted by Instrumentation Laboratory CO (Lexington, US). The FDA issued a Cleared decision on November 1, 1999 after a review of 81 days - a notably fast clearance cycle.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.7290 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Instrumentation Laboratory CO devices

FDA 510(k) Submission Details - K992704

510(k) Number K992704 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 12, 1999
Decision Date November 01, 1999
Days to Decision 81 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
32d faster than avg
Panel avg: 113d · This submission: 81d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GGP Device Classification - Class 2, Special Controls

Product Code GGP Test, Qualitative And Quantitative Factor Deficiency
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.7290
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - GGP Test, Qualitative And Quantitative Factor Deficiency

All 152
Devices cleared under the same product code (GGP) and FDA review panel - the closest regulatory comparables to K992704.
SYSMEX AUTOMATED COAGULATION ANALYZER, MODEL CA-1500
K000649 · Dade Behring, Inc. · Apr 2000
SHIELD VON WILLEBRAND FACTOR ACTIVITY ELISA, MODEL FVWF 200
K000398 · Shield Diagnostics, Ltd. · Apr 2000
GTI-FVIII INHIBITOR ASSAY
K993553 · Genetic Testing Institute · Feb 2000
BIOCLOT APC SENSITIVITY
K983898 · Biopool Intl., Inc. · Jan 1999
REAADS MONOCLONAL FREE PROTEIN S ANTIGEN TEST KIT
K983914 · Corgenix, Inc. · Dec 1998
VFE
K983107 · Ramco Laboratories, Inc. · Oct 1998